Optival Health Solutions, a subsidiary of Medplus, has received a 20-day suspension order for a drug license in Maharashtra effective from August 13, 2025, potentially impacting revenue by approximately Rs 15.60 lacs.
AI Assistant
Medplus Health Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.